jfapex

Daily Highlights - 19 November 2020

jfapex
Publish date: Thu, 19 Nov 2020, 08:31 AM
jfapex
0 116
JF Apex Research
Market Thoughts

 

US markets decline overnight after rising cases of coronavirus overshadowed optimism on the vaccine. Earlier, European stocks advanced as Pfizer's vaccine will be submitted to the US FDA for approval in several days.

 

On the local market, the FBM KLCI lost 5.40 points to 1604.75 points. Following the decline in Wall Street, the FBM KLCI could continue to hover below the resistance of 1615 points.

 

Among stocks to watch are Berjaya TotoSam EngineeringMatrix ConceptPetChemTA EnterpriseTA GlobalThong GuanTSH ResourcesAmwayBatu Kawan and KLK after announcing their quarterly results.

 

Malaysia News & Highlights

 

Quarterly Results

  • TA Enterprise and TA Global sink deeper into the red with bleeding hotel division
  • Media Prima returns to black in 3Q with RM12m net profit
  • KLK net profit up 19% in 4Q, sees better profit in FY21
  • Batu Kawan sees better year ahead; 4Q net profit falls due to unrealised derivatives, forex loss
  • Berjaya Sports Toto’s 1Q net profit up 1.34%
  • Lower oil prices drag PetChem 3Q net profit down by 15%
  • Sam Engineering 2Q net profit falls 25% as aerospace segment drags
  • TSH 3Q net profit jumps on higher CPO and PK prices
  • Thong Guan's 3Q net profit strengthens as it sells more premium products
  • Amway's 3Q net profit rises 47%

Company Developments and Outlooks

  • DGB Asia emerges as PUC’s substantial shareholder
  • Asia Poly buys 30% stake in acrylic manufacturer GB Plas for RM15m
  • Top Glove mops up more of own shares for seventh consecutive day, spends another RM69.94m

Foreign News

  • Dow falls more than 300 points for a second day of losses as rally to records pauses
  • European markets close higher with vaccine rally, virus spread in focus
  • Oil jumps to 11-week high on hope of OPEC+ supply increase delay (Overnight Closing)
  • Gold dips as vaccine progress offset worries over rising cases
  • Pfizer ends vaccine trial with 95% success rate; paving way for a shot this year

 

More articles on jfapex
Pesona Metro Holdings Berhad - Building the Future

Created by jfapex | Aug 26, 2024

Pesona is valued at RM0.46 based on a Sum of Parts valuation, which also corresponds to a 13.0x 1-year forward PER of the Group’s FY25F EPS of 3.5 sen. This valuation is a discount to Bursa Construc

Daily Highlights-21 January 2021

Created by jfapex | Jan 21, 2021

Daily Highlights-20 January 2021

Created by jfapex | Jan 20, 2021

Daily Highlights-19 January 2021

Created by jfapex | Jan 19, 2021

Daily Highlights-18 January 2021

Created by jfapex | Jan 18, 2021

Daily Highlights-15 January 2021

Created by jfapex | Jan 15, 2021

Daily Highlights-14 January 2021

Created by jfapex | Jan 14, 2021

Daily Highlights-13 January 2021

Created by jfapex | Jan 13, 2021

Daily Highlights-12 January 2021

Created by jfapex | Jan 12, 2021

Daily Highlights-11 January 2021

Created by jfapex | Jan 11, 2021